Heparin induced thrombocytopenia diagnosis in cardiac surgery: is there a role for thromboelastography?
The aim of the present protocol is to investigate the potency of thromboelastography (TEG) to screen postcardiac heparin induced thrombocytopenia (HIT) patients suspicious for HIT type II, and to differentiate which of them are subject to suffer thrombotic complications from those who will suffer hemorrhagic complications.
Kouerinis
Ilias A
IA
Department of Cardiac Surgery, Aghia Sophia Children's Hospital, Athens, Greece. ikouerinis@hotmail.com
Kourtesis
Antonios
A
El-Ali
Mahmoud
M
Sergentanis
Theodoros
T
Plagou
Athena
A
Argiriou
Michalis
M
Theakos
Nikolaos
N
Giannakopoulou
Aikaterini
A
D000925:Anticoagulants / Q000009:adverse effects*; D001777:Blood Coagulation / Q000187:drug effects; D006348:Cardiac Surgical Procedures; D003362:Cost-Benefit Analysis; D006115:Greece; D006470:Hemorrhage / Q000097:blood / Q000139:chemically induced*; D006493:Heparin / Q000009:adverse effects*; D006801:Humans; D011237:Predictive Value of Tests; D013916:Thrombelastography / Q000191:economics; D013921:Thrombocytopenia / Q000097:blood / Q000139:chemically induced / Q000150:complications / Q000175:diagnosis*; D013927:Thrombosis / Q000097:blood / Q000139:chemically induced*
D000925:Anticoagulants; D006493:Heparin